These findings provide a fresh framework for understanding GPR6 function with a detailed basis for structure-based drug design, offering hope for improved future treatments of Parkinson's disease.

Viva Biotech Holdings ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that for the Group's revenue during the Reporting Period achieved RMB1,986.7 million, gross profit ...

Research and postgraduate study in the area of drug design, development and delivery can focus on the design of novel therapeutic drugs and new delivery approaches. Multidisciplinary research areas ...

Azor Biotek is applying artificial intelligence solutions to the design and development of tailored, highly specific, novel small molecules, tapping into the vast potential of RNA drug targets.

A study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable of ...

But a novel strategy used by Astellas Pharma Inc ... One notoriously difficult-to-drug target is the protein KRAS, whose encoding gene is mutated in about one-quarter of all cancers.

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.